Comparing the ocular surface effects of topical vancomycin and linezolid for treating bacterial keratitis

Budak B., Baykara M., Kıvanç S. A., Yilmaz H., Cicek S.

CUTANEOUS AND OCULAR TOXICOLOGY, vol.35, no.2, pp.126-130, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 35 Issue: 2
  • Publication Date: 2016
  • Doi Number: 10.3109/15569527.2015.1058273
  • Journal Name: CUTANEOUS AND OCULAR TOXICOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.126-130
  • Bursa Uludag University Affiliated: Yes

Abstract

Background: Vancomycin is the gold standard in combination therapy for severe and resistant gram-positive keratitis and in particular for Methicillin-resistant Staphylococcus aureus (MRSA) infections. The aim of this study was to report the ocular surface toxicity and scoring in patients whose treatment shifted to topical linezolid/ceftazidime from topical vancomycin/ceftazidime due to their vancomycin intolerance.